News & Updates
Search Research Content
Resource Finder at Kennedy Krieger Institute
A free resource that provides access to information and support for individuals and families living with developmental disabilities.
Expression and clinical significance of the nin one binding protein and p38 MAPK in prostate carcinoma.
|Title||Expression and clinical significance of the nin one binding protein and p38 MAPK in prostate carcinoma.|
|Publication Type||Journal Article|
|Year of Publication||2013|
|Authors||Che J-P, Li W, Yan Y, Liu M, Wang G-C, Li Q-Y, Yang B, Yao X-D, Zheng J-H|
|Journal||International journal of clinical and experimental pathology|
Prostate carcinoma is a major cause of morbidity and mortality. The MAPK Signaling Pathway plays an important role in multiple tumors, including prostate carcinoma. MAPK signaling is mediated by ERK1/2, JNK and p38 MAPK, which are important in the control of cell proliferation, differentiation and apoptosis. However, relatively little is known about the regulatory mechanism of p38 MAPK in prostate cancers. NOB1 is among the most novel topic in MAPK studies currently. Recent studies found its vital role in tumor metastasis in glioblastoma proliferation, however, its expression profile and its prognostic value in prostate carcinoma have not been investigated.
|Alternate Journal||Int J Clin Exp Pathol|